---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-320325"
form_type: "8-K"
ticker: "FATE"
cik: "0001434316"
company_name: "FATE THERAPEUTICS INC"
filed_at: "2021-11-04T23:59:59+00:00"
generated_at: "2026-06-28T12:49:21.140951+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Fate Therapeutics files $350M ATM equity offering with Jefferies; terminates prior Leerink facility

## Summary
- Filed universal shelf registration on Form S-3ASR for common stock, preferred stock, debt securities, warrants, and units.
- Entered Open Market Sale Agreement with Jefferies to sell up to $350M of common stock in at-the-market offerings.
- Jefferies will receive a 3% commission on gross proceeds; company not obligated to sell any shares.
- Terminated prior at-the-market sales agreement dated November 21, 2018 with Leerink Partners effective upon filing.
- Either party may suspend or terminate the offering upon notice subject to conditions.

## SEC filing metadata
- accession: 0001193125-21-320325
- form_type: 8-K
- ticker: FATE
- cik: 0001434316
- company_name: FATE THERAPEUTICS INC
- filed_at: 2021-11-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434316/000119312521320325/0001193125-21-320325-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434316/000119312521320325/d212515d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-320325
- JSON: https://secwatch.observer/filing/0001193125-21-320325.json
- Plain text: https://secwatch.observer/filing/0001193125-21-320325.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.